Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Dana-Farber Cancer Institute
Boston, MA 02215
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2014 - 2015
Massachusetts General HospitalResidency, Internal Medicine, 2011 - 2014
Government Medical College ChandigrahClass of 2009
Certifications & Licensure
MA State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Anti-KRAS G12C and Anti-EGFR Rechallenge in Chemotherapy-RefractoryG12C-Mutated Colorectal Cancer: A Case Report.Linda Morris, Leontios Pappas, Aditya Pandey, Harshabad Singh, Samuel Klempner
JCO Precision Oncology. 2024-12-01 - Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer.Harshabad Singh, Joanne Xiu, Kevin S Kapner, Chen Yuan, Raja R Narayan
Clinical Cancer Research. 2024-11-01 - A Phase 1 Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.Brandon M Huffman, Osama E Rahma, Kevin Tyan, Yvonne Y Li, Anita Giobbie-Hurder
Cancer Immunology Research. 2024-09-30
Press Mentions
Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer in TrialMarch 14th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
